Princeton, NJ (PRWEB) November 10, 2016
As the healthcare industry evolves, re-engineering all healthcare products, digital and non, with patient-focused design will be key to crafting better patient experiences and transforming how the industry effectively communicates with patients. Medical Marketing & Media (MM&M)’s Transforming Healthcare Virtual Event Series: Patient-Focused Design, will examine the wide-ranging application of this thinking in healthcare, identify the latest trends in achieving patient engagement and share standout examples and new insights.
Michael Jarjour, President and CEO at ODH, Inc., a leading provider of behavioral health technology solutions and services, will discuss the current state of patient engagement and present how Mentrics, ODH’s leading-edge behavioral population health management solution, is advancing patient-focused applications.
WHEN & WHERE:
Webcast: The Transforming Healthcare Virtual Event Series: Patient-Focused Design, hosted by Medical Marketing & Media (MM&M)
Thursday, November 10, 2016, 11:00 a.m. EDT
For more information and to register, visit: http://www.mmm-online.com/webcasts/the-transforming-healthcare-virtual-event-series-patient-focused-design/article/560433/
Michael Jarjour is president and CEO at ODH, Inc., a provider of data analytics solutions for the behavioral health field. In this role, he oversees ODH's overall operations and drives strategy for its flagship product, Mentrics, the leading edge healthcare data analytics platform designed to transform behavioral healthcare systems. With more than 20 years of experience in pharmaceutical and healthcare technology, Mr. Jarjour has a proven track record of growing businesses, maximizing operations and building highly motivated and effective management teams on a global scale.
An entrepreneur, investor and advisor, Mr. Jarjour's extensive experience leading healthcare and technology companies to significant growth makes him the ideal executive to launch ODH. His leadership, strategic and operational strengths for steering companies and franchises toward greater growth and profitability have been recognized by his employers, peers and analysts.
Prior to leading ODH, Mr. Jarjour served as vice president, global commercialization and portfolio management at Otsuka Pharmaceutical and led the company's global digital strategy. Before that, he led Kinematik, a company focused on developing scientific R&D solutions, as president and CEO. Throughout his career, he has held key leadership positions at Bristol-Myers, Pharmacia/Pfizer, Warner-Lambert/Pfizer and Wyeth with particular focus on executive management, marketing, operations, strategy and business development.
About ODH, Inc.
ODH, Inc. is an innovative behavioral health technology and services solution company that leverages technology and clinical expertise to transform the delivery and economics of behavioral healthcare. ODH’s team of experts have decades of experience in the behavioral health, medical, clinical, pharmacy, business and data analytics and information technology fields, and is uniquely qualified to support the transformation of the management of behavioral healthcare. ODH is a subsidiary of Otsuka America, Inc. and part of the Otsuka Group of companies, an $11.9 billion global organization. Otsuka aspires to create new products for better health worldwide. ODH is a proud member of The White House’s Data-Driven Justice Initiative. For additional information on ODH, Inc., visit http://www.ODHSolutions.com and follow on Twitter @ODHInc.